Executive Summary Branded Generics Market Size and Share: Global Industry Snapshot CAGR Value:  The global branded generics market size was valued at USD 368.52 billion in 2024 and is expected to reach USD 683.63 billion by 2032, at a CAGR of 8.03% during the forecast period.   Businesses can depend with confidence upon this superior...

The Indian pharmaceutical industry has established itself as one of the most vital players in global healthcare. With its ability to produce high-quality drugs at affordable prices, India has earned the nickname “Pharmacy of the World.” From generic medicines and over-the-counter products to vaccines, biologics, and APIs (active pharmaceutical ingredients), Indian Pharma fills...

Introduction Rifaximin is an essential antibiotic used to treat various gastrointestinal conditions, including traveler’s diarrhea, irritable bowel syndrome (IBS) with diarrhea, and hepatic encephalopathy. Its unique property of being non-absorbable in the bloodstream makes it highly effective while minimizing systemic side effects. Given its significance in managing critical health...